Redhawk Wealth Advisors, Inc. Myriad Genetics Inc Transaction History

Redhawk Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$18.21 - $27.88 $45,980 - $70,397	2,525 Added 7.28%	37,205 $710,000
Q2 2022 Aug 25, 2022	BUY	$16.45 - $25.88 $49,646 - $78,105	3,018 Added 9.53%	34,680 $630,000
Q1 2022 Apr 21, 2022	BUY	$22.67 - $28.01 $354,445 - $437,936	15,635 Added 97.55%	31,662 $798,000
Q4 2021 Feb 11, 2022	BUY	$24.13 - $32.63 $98,257 - $132,869	4,072 Added 34.06%	16,027 $442,000
Q3 2021 Nov 02, 2021	BUY	$29.97 - $36.66 $358,291 - $438,270	11,955 New	11,955 $386,000

228

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $865M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Redhawk Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Redhawk Wealth Advisors, Inc. with notifications on news.